NASHVILLE, Tenn.–(BUSINESS WIRE)–MyWoundDoctor, a leader in providing expert wound care management, announced the appointment of Donato Tramuto to its Board of Directors. Tramuto is a recognized healthcare innovator, leader, and philanthropist with more than 40 years of industry experience. He served as CEO of Tivity Health, a public company providing health and vitality solutions to commercial and Medicare Advantage plans, and he holds numerous leadership and advisory roles across prominent healthcare businesses and nonprofits.
“I had the privilege of working with Donato as part of his leadership team at Tivity Health. He’s an inspiring person who drove sustainable operating and financial results by putting forward a clear vision and strategy and gaining support across the organization,” said Steve Janicak, chief executive officer of MyWoundDoctor. “At MyWoundDoctor, we believe that everyone should have access to expert wound care wherever they are. Donato has a long and proven history of using technology solutions to deliver quality healthcare to patients in unique and challenging circumstances. His experience, perspective, and determination will be invaluable to our team.”
At Tivity Health, Tramuto executed a turnaround of the company’s business six months into his tenure, including the innovative sale of a sub-performing division, which added nearly $1 billion of value to the company’s market capitalization. In 2008, Tramuto founded Physicians Interactive Holdings (now known as Aptus Health), a global provider of insight-driven digital engagement solutions for healthcare professionals and consumers.
As a philanthropist, Tramuto founded Health eVillages, a nonprofit that provides state-of-the-art mobile health technology in the most challenging clinical environments. He is also chairman and founder of the TramutoPorter Foundation, which helps individuals and organizations achieve their educational and healthcare goals.
“I’m honored to join the board of such an incredibly promising company with a vital and timely mission,” said Tramuto. “MyWoundDoctor brings together many things that have driven me throughout my career – delivering deep, concentrated healthcare expertise with digital solutions that make it easier for patients and providers. I’m excited to work with a board and management team that I know first-hand to be talented, passionate, and results-oriented leaders.”
Tramuto serves on several executive leadership boards, including the Boston University School of Public Health, Robert F. Kennedy Human Rights U.S. and Italy, Cherish Health, Zeel Health, Gryphon Partners, and Y2X Life Sciences. In addition, he is executive-in-residence at Sharecare, Concierge Health, Promerica Health, Skyscape, and Gento Health. He also serves as an Honorary Scholar in Residence at St. Joseph’s College in Standish, Maine.
Tramuto is also an accomplished writer, having published two books: “Life’s Bulldozer Moments: How Adversity Leads to Success in Life and Business” and, most recently, “The Double Bottom Line: How Compassionate Leaders Captivate Hearts and Deliver Results.”
About MyWoundDoctor
MyWoundDoctor believes everyone should have access to expert wound care. MyWoundDoctor provides deep, concentrated wound care expertise from specialized physicians and nurses, informed by data. The company delivers responsive care plans developed from evidence-based guidelines and uses technology to make care easy for patients and providers wherever they are. Learn more at https://www.mywounddoctor.com/.
Contacts
HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…
This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…
Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…
SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…
MIAMI, FL / ACCESSWIRE / December 23, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the…